REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Intech Biopharm Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Intech Biopharm Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Intech Biopharm focuses mainly on developing drugs for obstructive airway diseases such as bronchial asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2010 and is headquartered in New Taipei City.

Headquarters
3F., No.36, Ln. 358, Ruiguang Rd, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Intech Biopharm Ltd. report to view the information.

Website: http://www.intechbiopharm.com

Basic Information
Total Employees:
Purchase the Intech Biopharm Ltd. report to view the information.
Outstanding Shares:
Purchase the Intech Biopharm Ltd. report to view the information.
Financial Auditors:
Purchase the Intech Biopharm Ltd. report to view the information.
Incorporation Date:
October 28, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
40.44%
Purchase this report to view the information.
5.55%
Purchase this report to view the information.
0.36%
Purchase this report to view the information.
0.14%
Purchase this report to view the information.
0.09%
Subsidiaries
Time Deposits with Original Maturity Over
0.54%
Company Performance
Financial values in the chart are available after Intech Biopharm Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
47.49%▲
Total operating revenue
94.23%▲
Operating profit (EBIT)
-5.79%▼
EBITDA
-16.18%▼
Net Profit (Loss) for the Period
-8.83%▼
Total assets
3.29%▲
Total equity
13.89%▲
Operating Profit Margin (ROS)
303.72%▲
Net Profit Margin
297.91%▲
Return on Equity (ROE)
0.78%▲
Debt to Equity Ratio
7.55%▲
Quick Ratio
0.52%▲
Cash Ratio
0.23%▲

Similar companies

Lotus Pharmaceutical Co., Ltd.
 
Great Tree Pharmacy Co.,Ltd.
Bora Pharmaceuticals Co., Ltd.
 
China Chemical & Pharmaceutical Co., Ltd
PharmaEssentia Corp.
 
Pharmally International Holding Co., Ltd
AP Biosciences Inc
 
Formosa Pharmaceuticals, Inc.
Life Fusion Inc.
 
UnicoCell Biomed Co., Ltd.
Acer Medical Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo